Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc's enterprise value is currently approximately $430 million, which presents a potential for significant upside of 8-10 times the current share price if its partnership with Novo unfolds successfully. The company is advancing multiple candidates in its pipeline, particularly with SEP-631 showing promising results in Phase 1 trials, while SEP-479 has exhibited preclinical efficacy comparable to leading therapies and demonstrated favorable safety profiles in toxicology studies. With the potential for SEP-631 to achieve blockbuster status akin to Xolair, the therapeutic promise of Septerna's diverse pipeline positions the company favorably within the biotechnology sector.

Bears say

Septerna Inc faces significant risks that negatively impact its stock outlook, primarily stemming from potential delays in the clinical development of its drug candidates, including SEP-631, which could hinder progress in bringing products to market. Additionally, setbacks in clinical trials could derail the advancement of key therapies, while partnership uncertainties, particularly with Novo Nordisk, heighten the risk of collaboration instability. Lastly, concerns regarding the ability to secure regulatory approvals, achieve market penetration expectations, and the possibility of long-term dilution add to the overall financial uncertainty surrounding the company.

Septerna Inc (SEPN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.